Hem › Metastaserande cancer › South Carolina › Myrtle Beach
Kliniska studier för Metastaserande cancer i Myrtle Beach, SC
5 studier för Metastaserande cancer söker deltagare vid platser i och runt Myrtle Beach (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
RekryterarFas 1/2
- Avenzo Therapeutics Recruiting Site, Myrtle Beach
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekryterarFas 1/2
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekryterarFas 1
- Carolina Urologic Research Center, Myrtle Beach
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekryterarFas 1
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RekryterarFas 1
- Carolina Urologic Research Center, Myrtle Beach
Metastaserande cancer-studier i andra städer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andra studier i Myrtle Beach
- Prostatacancer24 studier
- Blåscancer10 studier
- Icke-muskelinvasiv blåscancer9 studier
- Njurcancer (renalcelskarcinom)6 studier
- Urotelial (övergångscells-)karcinom5 studier
- Typ 2-diabetes3 studier
- Kastringsresistent prostatacancer3 studier
- Cancer (alla typer)3 studier
- Carcinom in situ3 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.